@bushcow6
Active 9 hours, 18 minutes ago
Low-dose, weekly cisplatin (40 mg/m
) regimens are currently utilized at Eskenazi Health in Indianapolis, Indiana for the treatment of head and neck cancer due to enhanced tolerability. This retrospective analysis analyzes the incidence, severity, and risk factors for AKI in patients who received this regimen.
A retrospective chart r […] View
